<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZZ4U7BB8</identifier><date>2012</date><creator>Rener, Karla</creator><creator>Zver, Samo</creator><relation>documents/doc/Z/URN_NBN_SI_doc-ZZ4U7BB8_001.htm</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZZ4U7BB8_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZZ4U7BB8_001.txt</relation><format format_type="volume">81</format><format format_type="type">article</format><format format_type="extent">str. II-104-II-112</format><format format_type="issue">suppl.</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">695724</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZZ4U7BB8</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">esencialna trombocitemija</subject><subject language_type_id="eng">essential thrombocythemia</subject><subject language_type_id="slv">hematologija</subject><subject language_type_id="eng">JAK 2 mutation</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="eng">treatment</subject><subject language_type_id="slv">zdravljenje</subject><title>Značilnosti in zdravljenje bolnikov z esencialno trombocitemijo v obdobju 2008-2011</title><title>Characteristics and treatment of patients with essential thrombocythemia during the period of 2008-2011</title></Record>